Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization ; volume:21 ; number:1 ; day:17 ; month:5 ; year:2021 ; pages:1-10 ; date:12.2021
Cancer cell international ; 21, Heft 1 (17.5.2021), 1-10, 12.2021
- Urheber
-
Sajjadi, Elham
Venetis, Konstantinos
Piciotti, Roberto
Invernizzi, Marco
Guerini-Rocco, Elena
Haricharan, Svasti
Fusco, Nicola
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-021-01976-y
- URN
-
urn:nbn:de:101:1-2021091623040422176869
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sajjadi, Elham
- Venetis, Konstantinos
- Piciotti, Roberto
- Invernizzi, Marco
- Guerini-Rocco, Elena
- Haricharan, Svasti
- Fusco, Nicola
- SpringerLink (Online service)
Ähnliche Objekte (12)
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
The biology and molecular vulnerabilities of ATM-deficient cancers
Testing for deficient mismatch repair and microsatellite instability : A focused update
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Evaluation of human and murine frameshift peptide neoantigens for the development of a preventive vaccine against Lynch syndrome-associated mismatch repair deficient cancers
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
The biology and molecular vulnerabilities of ATM-deficient cancers
Testing for deficient mismatch repair and microsatellite instability : A focused update
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Evaluation of human and murine frameshift peptide neoantigens for the development of a preventive vaccine against Lynch syndrome-associated mismatch repair deficient cancers
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
The biology and molecular vulnerabilities of ATM-deficient cancers
Testing for deficient mismatch repair and microsatellite instability : A focused update
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Evaluation of human and murine frameshift peptide neoantigens for the development of a preventive vaccine against Lynch syndrome-associated mismatch repair deficient cancers